FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2776373997> ?p ?o ?g. }

• W2776373997 abstract "The number of bariatric interventions for morbid obesity is increasing worldwide. Rapid weight loss is a major risk factor for gallstone development. Approximately 11 % of patients who underwent Roux-en-Y gastric bypass develop symptomatic gallstone disease. Gallstone disease can lead to severe complications and often requires hospitalization and surgery. Ursodeoxycholic acid (UDCA) prevents the formation of gallstones after bariatric surgery. However, randomized controlled trials with symptomatic gallstone disease as primary endpoint have not been conducted. Currently, major guidelines make no definite statement about postoperative UDCA prophylaxis and most bariatric centers do not prescribe UDCA. A randomized, placebo-controlled, double-blind multicenter trial will be performed for which 980 patients will be included. The study population consists of consecutive patients scheduled to undergo Roux-en-Y gastric bypass or sleeve gastrectomy in three bariatric centers in the Netherlands. Patients will undergo a preoperative ultrasound and randomization will be stratified for pre-existing gallstones and for type of surgery. The intervention group will receive UDCA 900 mg once daily for six months. The placebo group will receive similar-looking placebo tablets. The primary endpoint is symptomatic gallstone disease after 24 months, defined as admission or hospital visit for symptomatic gallstone disease. Secondary endpoints consist of the development of gallstones on ultrasound at 24 months, number of cholecystectomies, side-effects of UDCA and quality of life. Furthermore, cost-effectiveness, cost-utility and budget impact analyses will be performed. The UPGRADE trial will answer the question whether UDCA reduces the incidence of symptomatic gallstone disease after Roux-en-Y gastric bypass or sleeve gastrectomy. Furthermore it will determine if treatment with UDCA is cost-effective. Netherlands Trial Register (trialregister.nl) 6135 . Date registered: 21-Nov-2016." @default.
• W2776373997 created "2018-01-05" @default.
• W2776373997 creator A5003840687 @default.
• W2776373997 creator A5013502327 @default.
• W2776373997 creator A5026461028 @default.
• W2776373997 creator A5039847329 @default.
• W2776373997 creator A5051832095 @default.
• W2776373997 creator A5063976596 @default.
• W2776373997 creator A5069316397 @default.
• W2776373997 creator A5071037040 @default.
• W2776373997 creator A5077855205 @default.
• W2776373997 creator A5080672354 @default.
• W2776373997 creator A5082287042 @default.
• W2776373997 creator A5082755767 @default.
• W2776373997 creator A5083462005 @default.
• W2776373997 creator A5084175310 @default.
• W2776373997 creator A5084817085 @default.
• W2776373997 date "2017-12-01" @default.
• W2776373997 modified "2023-10-09" @default.
• W2776373997 title "Ursodeoxycholic acid for the prevention of symptomatic gallstone disease after bariatric surgery: study protocol for a randomized controlled trial (UPGRADE trial)" @default.
• W2776373997 cites W1799739187 @default.
• W2776373997 cites W1947512943 @default.
• W2776373997 cites W1968500454 @default.
• W2776373997 cites W1971990083 @default.
• W2776373997 cites W1975901838 @default.
• W2776373997 cites W1991272493 @default.
• W2776373997 cites W1991928809 @default.
• W2776373997 cites W1992790247 @default.
• W2776373997 cites W2005097091 @default.
• W2776373997 cites W2005659601 @default.
• W2776373997 cites W2018776483 @default.
• W2776373997 cites W2023286299 @default.
• W2776373997 cites W2027044236 @default.
• W2776373997 cites W2031306699 @default.
• W2776373997 cites W2033698279 @default.
• W2776373997 cites W2033894625 @default.
• W2776373997 cites W2037006931 @default.
• W2776373997 cites W2038525929 @default.
• W2776373997 cites W2052693098 @default.
• W2776373997 cites W2053348662 @default.
• W2776373997 cites W2053529274 @default.
• W2776373997 cites W2054566891 @default.
• W2776373997 cites W2055001433 @default.
• W2776373997 cites W2072970915 @default.
• W2776373997 cites W2074820476 @default.
• W2776373997 cites W2080480619 @default.
• W2776373997 cites W2088136891 @default.
• W2776373997 cites W2101737556 @default.
• W2776373997 cites W2104437955 @default.
• W2776373997 cites W2119679249 @default.
• W2776373997 cites W2144256005 @default.
• W2776373997 cites W2145758369 @default.
• W2776373997 cites W2160336403 @default.
• W2776373997 cites W2163393830 @default.
• W2776373997 cites W2170628858 @default.
• W2776373997 cites W2562935783 @default.
• W2776373997 cites W4251788912 @default.
• W2776373997 cites W4253938058 @default.
• W2776373997 doi "https://doi.org/10.1186/s12876-017-0674-x" @default.
• W2776373997 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5738131" @default.
• W2776373997 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29262795" @default.
• W2776373997 hasPublicationYear "2017" @default.
• W2776373997 type Work @default.
• W2776373997 sameAs 2776373997 @default.
• W2776373997 citedByCount "36" @default.
• W2776373997 countsByYear W27763739972018 @default.
• W2776373997 countsByYear W27763739972019 @default.
• W2776373997 countsByYear W27763739972020 @default.
• W2776373997 countsByYear W27763739972021 @default.
• W2776373997 countsByYear W27763739972022 @default.
• W2776373997 countsByYear W27763739972023 @default.
• W2776373997 crossrefType "journal-article" @default.
• W2776373997 hasAuthorship W2776373997A5003840687 @default.
• W2776373997 hasAuthorship W2776373997A5013502327 @default.
• W2776373997 hasAuthorship W2776373997A5026461028 @default.
• W2776373997 hasAuthorship W2776373997A5039847329 @default.
• W2776373997 hasAuthorship W2776373997A5051832095 @default.
• W2776373997 hasAuthorship W2776373997A5063976596 @default.
• W2776373997 hasAuthorship W2776373997A5069316397 @default.
• W2776373997 hasAuthorship W2776373997A5071037040 @default.
• W2776373997 hasAuthorship W2776373997A5077855205 @default.
• W2776373997 hasAuthorship W2776373997A5080672354 @default.
• W2776373997 hasAuthorship W2776373997A5082287042 @default.
• W2776373997 hasAuthorship W2776373997A5082755767 @default.
• W2776373997 hasAuthorship W2776373997A5083462005 @default.
• W2776373997 hasAuthorship W2776373997A5084175310 @default.
• W2776373997 hasAuthorship W2776373997A5084817085 @default.
• W2776373997 hasBestOaLocation W27763739971 @default.
• W2776373997 hasConcept C126322002 @default.
• W2776373997 hasConcept C141071460 @default.
• W2776373997 hasConcept C168563851 @default.
• W2776373997 hasConcept C203092338 @default.
• W2776373997 hasConcept C2776641081 @default.
• W2776373997 hasConcept C2778586554 @default.
• W2776373997 hasConcept C2779388726 @default.
• W2776373997 hasConcept C2780965833 @default.
• W2776373997 hasConcept C2908647359 @default.
• W2776373997 hasConcept C3019402062 @default.
• W2776373997 hasConcept C41260117 @default.
• W2776373997 hasConcept C511355011 @default.

• next